1 As pharmacokinetic dierences between the thiopentone enantiomers seem insucient to explain the *2 fold greater potency for CNS eects of (7)-S-over (+)-R-thiopentone, this study was performed to determine any enantioselectivity of thiopentone at the GABA A receptor, the primary receptor for barbiturate hypnotic eects. 2 Two electrode voltage clamp recording was performed on Xenopus laevis oocytes expressing human GABA A receptor subtype a 1 b 2 g 2 to determine relative dierences in potentiation of the GABA response by rac-, (+)-R-and (7)-S-thiopentone, and rac-pentobarbitone. Changes in the cellular environment pH and in GABA concentrations were also evaluated. 3 With 3 mM GABA, the EC 50 values were (7)-S-thiopentone (mean 26.0+s.e.mean 3.2 mM, n=9 cells) 4rac-thiopentone (35.9+4.2 mM, n=6, P=0.1) 4(+)-R-thiopentone (52.5+5.0 mM, n=8, P50.02) 4rac-pentobarbitone (97.0+11.2 mM, n=11, P50.01). Adjustment of environment pH to 7.0 or 8.0 did not alter the EC 50 values for (+)-R-or (7)-S-thiopentone. 4 Uninjected oocytes responded to 4100 mM (7)-S-and R-thiopentone. This direct response was abolished by intracellular oocyte injection of 1,2-bis(2-aminophenoxy)ethane-N,N,N1,N1-tetraacetic acid (BAPTA), a Ca 2+ chelating agent. With BAPTA, the EC 50 values were (7)-S-thiopentone (20.6+3.2 mM, n=8) 5(+)-R-thiopentone (36.2+3.2 mM, n=9, P50.005). 5 (7)-S-thiopentone was found to be *2 fold more potent than (+)-R-thiopentone in the potentiation of GABA at GABA A receptors expressed on Xenopus oocytes. This is consistent with the dierences in potency for CNS depressant eects found in vivo.
Introduction
The main inhibitory neurotransmitter, g-aminobutyric acid (GABA), activates the three major classes of GABA receptors: GABA A , GABA B and GABA C (Johnston, 1996) . The GABA A receptor is a ligand-gated chloride channel assembled from 14 dierent glycoprotein subunits (a 1 ± 6 , b 1 ± 3 , g 1 ± 3 , d and e), in which 2a, 2b and one of either g, d or e subunits combine to form a functional receptor complex (Tanelian et al., 1993) . The majority of receptor subtypes found in most regions of the rat brain possess an a 1 subunit (Mohler et al., 1992) . The a 1 b 2 g 2 receptor complex is also considered a dominant human receptor subunit combination in vivo (Lambert et al., 1997) . Barbiturates primarily exert their sedative and anaesthetic eects by potentiation of the GABA response at GABA A receptors (Huang & Barker 1980; Leeb-Lundberg & Olsen 1982; Akaike et al., 1985; Peters et al., 1988; Thompson et al., 1996; rench-Mullen et al., 1993) . Electrophysiological studies have shown that this potentiation is due to a prolongation in duration of the chloride ion channel opentime (Mathers & Barker, 1980) . Barbiturates are also capable of direct activation of GABA A receptors and, at high concentrations, may block the chloride channel (Peters et al., 1988; Thompson et al., 1996) .
Thiopentone diers from pentobarbitone by the replacement of oxygen with sulphur at the C2 position of the barbiturate ring. This substitution confers upon thiopentone dierent pharmacological properties, particularly a more rapid onset of action and a reduction in the terminal elimination half-life from 30 ± 50 h to 10 ± 15 h (Chan et al., 1985) , that convey clinical advantages. Recent studies also suggest that rac-thiopentone possesses neuroprotective advantages over pentobarbitone due to rac-thiopentone's ability to inhibit nitric oxide induced cytotoxicity, and over propofol by means of rac-thiopentone's attenuation of NMDA-and AMPAmediated glutamate excitotoxicity (Shibuta et al., 1998; Zhu et al., 1997) . Thiopentone has also been shown to impair astrocyte glutamate uptake at concentrations relevant to its clinical use (Swanson & Seid, 1998) . Nevertheless, the utility of prolonged high-dose rac-thiopentone therapy for neurological and neurosurgical emergencies as well as prolonged anaesthesia is limited by its association with cardiac depression and by a prolonged duration of eect related to non-linear pharmacokinetics (Stanski et al., 1980; Turcant et al., 1985; Le Corre et al., 1993; Russo et al., 1996) .
Thiopentone is a racemate used as an equimolar mixture of (+)-R-and (7)-S-enantiomers; thus it should strictly be designated RS-, (+) or rac-thiopentone to designate its racemic nature. Pentobarbitone has the same con®guration and signs of the optical rotations as thiopentone but was only used as the racemate. As the signs of the optical rotations are not of signi®cance to this study, they have been deleted for simplicity. The potential for dierences in the pharmacokinetics and pharmacodynamics of enantiomers of racemic drugs, including a number of barbiturates, is well known (Mather & Rutten, 1991) . Despite its long history of clinical use, there has only been a limited study of the pharmacological dierences between the thiopentone enantiomers. It has been reported that S-thiopentone is a more potent hypnotic than Rthiopentone in mice (Christensen & Lee 1973; Haley & Gidley 1976) , humans (Mark et al., 1977) and rats (Mather et al., 1999a) . Although recent studies have identi®ed various pharmacokinetic dierences between R-and S-thiopentone (Mather et al., 1996 (Mather et al., , 1999c Nguyen et al., 1996; Cordato et al., 1997 Cordato et al., , 1999 , the dierences would seem too small to explain the pharmacodynamic dierences.
In this study, we investigated the relative dierences in potentiation of the GABA response at GABA A receptor subtype a 1 b 2 g 2 , expressed in Xenopus laevis oocytes, by racthiopentone, its R-and S-enantiomers and rac-pentobarbitone. We also evaluated the eects of changes in the pH of the cellular environment, as this may in¯uence drug receptor binding along with alterations to the degree of drug ionization, and compared the EC 50 values of R-and S-thiopentone and rac-pentobarbitone in the presence of lower (3 mM) and higher (15 mM) GABA concentrations.
Methods
Human GABA A receptor cDNAs 
Drug preparations
Drugs used were: R-and S-thiopentone (Huang et al., 1996) , rac-thiopentone sodium, rac-pentobarbitone sodium, g-aminobutyric acid and 1,2-bis(2-aminophenoxy)ethane-N,N,N 1 ,N 1 =tetraacetic acid [BAPTA] (Sigma Chemical Co, St Louis, MO, U.S.A.). R-and S-thiopentone (0.1 mmoles) were dissolved in 0.5 ml 4 M NaOH and 9.5 ml ND96 recording solution (mM) (NaCl 96, KCl 2, MgCl 2 .6H 2 O 1, CaCl 2 1.8, HEPES 5, pH 7.5) to give 10 mM solutions. Further dilutions with the same recording solution were performed to make the ®nal concentrations used in the electrophysiological studies. rac-Thiopentone was prepared from a 50 : 50 mixture of the R-and S-thiopentone solutions and the electrophysiological ®ndings were comparable to those obtained from racthiopentone sodium (Sigma). The pH of higher concentrations (450 mM) of R-and S-thiopentone, rac-thiopentone and pentobarbitone was adjusted to pH 7.5 using 0.5 ± 10 ml 2 M HCl, where appropriate.
Electrophysiological recording
Female Xenopus laevis were anaesthetized with 0.17% 3-aminobenzoic acid ethyl ester. A lobe of the ovaries was removed, rinsed with OR2 buer (mM) (NaCl 82.5, KCl 2, MgCl 2 .6H 2 O 1, HEPES 5, pH 7.5) and treated with collagenase A (2 mg ml 71 in OR-2, Boehringer Mannheim) for 2 h to separate oocytes from connective tissue and follicular cells. Released oocytes were then rinsed in ND96 storage solution (mM) (NaCl 96, KCl 2, MgCl 2 .6H 2 O 1, CaCl 2 1.8, HEPES 5, pH 7.5 supplemented with 2.5 mM pyruvate, 0.5 mM theophylline and 50 mM ml 71 gentamicin). Stage V to V1 oocytes were collected and stored in ND96 solution with constant mixing on an orbital shaker.
An amount of 50 ng 50 nl 71 of a 1 , b 2 and g 2 cRNA in the ratio of 1 : 1 : 1 was injected into the cytoplasm of defolliculated Stage V Xenopus oocytes. Oocytes were stored at 98C in ND96 storage solution; 2 ± 8 days after mRNA injection, receptor activity was measured by two electrode voltage clamp recording using a Geneclamp 500 ampli®er (Axon Instruments Inc., Foster City, CA, U.S.A.), MacLab 2e recorder (AD Instruments, Sydney, NSW, Australia) and Chart version 3.5.2 software on a Macintosh Quadra 605 computer. Oocytes were placed in a cell bath and voltage clamped using two micropipettes containing 3 M KCl. The membrane potential was clamped at 760 mV and the oocyte continually superfused with ND96 recording solution. Before any recording, oocytes were screened for functional receptor formation by the addition of 3 mM and 100 mM GABA to the cell bath. Dierent concentrations of drugs being tested were added to the buer solution for receptor activation measurements. The drugs were applied until a peak response was observed, followed by a 3 min washout period to avoid receptor desensitization.
pH adjustments
The pH of the buer solutions containing dierent concentrations of R-and S-thiopentone was adjusted to pH 7.0 or 8.0 using small amounts (50.1% buer volume) of 2 M HCl or NaOH to determine any eect on the degree of GABA potentiation in the presence of 3 mM GABA.
Analysis of electrophysiological data
Current (`I ') dose-response relationships were measured from the recorded peak amplitude of I obtained for each drug concentration. The parameters of the relationship between`I ' and agonist concentration [A] were determined from the least squares ®t of the Hill equation`I '=`I max ' [A] nH /(EC 50 nH +[A] nH ) to the data (where`I max ' is the maximal current, EC 50 is the eective dose that activates 50% of the maximal current for n individual cells and n H is the Hill coecient). The EC 50 values, expressed as the mean+s.e.mean from a number of dierent cells (n), were calculated by ®tting data from individual oocytes using Kaleidograph 2.1 software. The statistical signi®cance of dierences between mean EC 50 values was determined by oneway analysis of variance (ANOVA).
Results
Expression of human a 1 b 2 g 2 mRNA in Xenopus oocytes generated GABA A receptors that showed a dose-dependent GABA-activated inward current when the cell was voltage clamped at 760 mV. The log dose-response curve gave an EC 50 value of 32.1 mM (n=5 cells, s.e.mean 5.7) and a Hill coecient of 1.3 (s.e.mean 0.1). The eects of R-thiopentone, S-thiopentone, rac-thiopentone and rac-pentobarbitone on the GABA A a 1 b 2 g 2 receptor subtype were studied in the presence of 3 and 15 mM GABA. The degree of potentiation was measured by subtracting the current (`I ') produced by GABA, 3 or 15 mM respectively, in the absence of agonist drug from the absolute current (`I ') value produced in the presence of agonist drug. The direct activation component of the agonist drug, however, was included in the potentiation response value. For R-thiopentone, S-thiopentone and racthiopentone, 490% of the maximal GABA potentiation response was achieved with 100 mM agonist drug concentrations. For rac-pentobarbitone, 300 mM concentrations were required to achieve 490% of the maximal GABA potentiation response. In contrast, direct activation of the GABA A receptor by 100 mM S-thiopentone and R-thiopentone produced responses that were 13 and 5%, respectively, of the maximal GABA potentiation response.
Xenopus oocytes not injected with human a 1 b 2 g 2 mRNA were found also to respond to 4100 mM concentrations of Rand S-thiopentone. This direct response was not seen with 1 mM rac-pentobarbitone. In uninjected oocytes, the respective median currents produced by 100 mM and 1 mM S-thiopentone were 15 nA (range 5 ± 50 nA, n=5) and 150 nA (range 20 ± 500 nA, n=7); the respective median currents produced by 100 mM and 1 mM R-thiopentone were 10 nA (range 2 ± 20 nA, n=5) and 50 nA (range 20 ± 200 nA, n=5). In Xenopus oocytes injected with human a 1 b 2 g 2 mRNA, the respective median currents produced by 100 mM and 1 mM R-thiopentone were 120 nA (range 5 ± 260 nA, n=11) and 720 nA (range 140 ± 1500 nA, n=5); the respective median currents produced by 100 mM and 1 mM R-thiopentone were 50 nA (range 2-115 nA, n = 10) and 250 nA (range 60 ± 600 nA, n=5). Hence, a dose-related and enantioselective dierence was apparent in the endogenous direct responses produced. Endogenous receptor responses, including muscarinic cholinergic and voltage-sensitive calcium-dependent chloride currents, have been previously described in Xenopus oocytes (Kusano et al., 1982; Miledi & Parker 1984) . Atropine (1 mM) did not signi®cantly alter the response of 1 mM R-or S-thiopentone on uninjected cells. Intracellular injection of 50 nl 50 mM BAPTA, a Ca 2+ chelating agent that was injected into the Xenopus oocytes at least 30 min prior to electrophysiological recording, virtually completely abolished the direct response to 1 mM R-and S-thiopentone. Hence further electrophysiological experiments comparing the degree of potentiation of the 3 mM GABA response by R-and S-thiopentone were carried out in Xenopus oocytes injected intracellularly with 50 mM BAPTA.
Electrophysiological responses in the absence of intracellular BAPTA
The EC 50 for potentiation of 3 mM GABA by Rthiopentone was signi®cantly greater than the EC 50 for rac-thiopentone and S-thiopentone (P=0.02 and P=0.0004, respectively). In contrast, the EC 50 for rac-pentobarbitone was greater than that for R-thiopentone (P=0.007). The EC 50 and Hill coecient for rac-pentobarbitone in the presence of 15 mM GABA were both comparable to previously reported values (Thompson et al., 1996) . The EC 50 values for potentiation of 15 mM GABA by racpentobarbitone, R-thiopentone and S-thiopentone were signi®cantly less than those for the potentiation of 3 mM GABA (P=0.004, P=0.002 and P=0.04, respectively) by each agonist. The ratios of`I max '/1 mM GABA responses, however, were similar for both 3 and 15 mM GABA. Figures 1 and 2 illustrate the typical current responses of R-and S-thiopentone. The concentration-response curves for R-thiopentone, S-thiopentone, rac-thiopentone and racpentobarbitone, respectively, are shown in Figure 3 . The EC 50 values, Hill coecients and ratios of`I max '/1 mM GABA response are summarized in Table 1 .
The results of an adjustment in the environment of the cell bath to pH 7.0 and to 8.0 are also shown in Table 1 . Although the concentration-response curves showed a trend towards a shift to the left at the lower pH, the mean dierences in EC 50 values were not signi®cantly dierent (P=0.08 and P=0.27 for R-thiopentone and S-thiopentone, respectively). 
Electrophysiological responses in the presence of intracellular BAPTA
The EC 50 for potentiation of 3 mM GABA by S-thiopentone (20.6+3.2 mM, n=7 cells) was again signi®cantly less than that for R-thiopentone (36.2+3.2 mM, n=8 cells, P50.005). The EC 50 for potentiation of 3 mM GABA by R-thiopentone in the presence of BAPTA was signi®cantly less than that for potentiation of 3 mM GABA in the absence of BAPTA (P=0.02). The EC 50 values, however, were not signi®cantly dierent for S-thiopentone (P=0.20).
Adjustment of the pH environment to 7.0, in the presence of BAPTA, did not signi®cantly alter the EC 50 values for R-and S-thiopentone when compared to those at pH 7.5. The EC 50 values, Hill coecient and ratio of`I max '/100 mM GABA responses at pH 7.0 and 7.5, in the presence of BAPTA, are summarized in Table 2 .
Discussion
Intravenous rac-thiopentone remains the most widely used agent for the induction of anaesthesia after more than six decades of clinical use. During the last two decades, prolonged high dose rac-thiopentone aimed at achieving marked electroencephalographic (EEG) slowing or EEG burstsuppression activity has been introduced for treating acute neurological and neurosurgical emergencies, but is usually restricted to refractory cases due to haemodynamic side-eects and an unwanted and prolonged post-infusion duration of clinical unresponsiveness. We have been considering the question of whether enantiopure thiopentone might oer pharmacological advantages over the currently-used racemate. R-thiopentone is less potent than S-thiopentone in producing anaesthesia and lethality. It has been reported that the median anaesthetic and lethal doses for R-thiopentone in mice were approximately 2 fold greater than S-thiopentone (Christensen & Lee, 1973) . Moreover, longer sleep duration times were *S-and R-thi refer to (7)-S-and R-(+)-thiopentone, respectively, and R+S-thi and R+S-pent refer to rac-thiopentone and racpentobarbitone, respectively. {GABA conc./pH refer to the GABA concentration that was present in combination with dierent concentrations of agonist drug and the pH of the drug solution/cell bath. #Data are the mean+s.e.mean. ##`I max ' refers to the ratio of the maximal current produced by agonist drug in combination with the GABA concentration (de®ned in column 2) minus the current produced by that GABA concentration to the current produced by 1mM GABA. *S-and R-thi refer to (7)-S-and (+)-R-thiopentone, respectively. {GABA conc./pH refer to the GABA concentration that was present in combination with dierent concentrations of agonist drug and the pH of the drug solution/cell bath. BAPTA is 1,2-bis(2-aminophenoxy)ethane-N,N,N 1 ,N 1 -tetraacetic acid.
# Data are the mean+s.e. mean. ##`I max ' refers to the ratio of the maximal current produced by agonist drug in combination with the GABA concentration (de®ned in column 2) minus the current produced by that GABA concentration to the current produced by 1 mM GABA. found for S-thiopentone than R-thiopentone in three human subjects administered 300 mg of either enantiomer (Mark et al., 1977) . It has also been found that R-thiopentone has a greater relative distribution into CNS tissues and lesser distribution into cardiac tissues in rats, and this probably contributes to its higher therapeutic index (Mather et al., 1999b) . The present studies indicate that the lower potency of R-thiopentone may be related to its lesser activity at the GABA A receptor.
Barbiturates (Leeb-Lundberg & Olsen 1982; Johnston 1983; Lohse et al., 1987; Olsen et al., 1986; Richter & Holtman 1982) . For example, it has been found that the relative potencies (IC 50 values) for the inhibition of [
35 S]-TBPT binding increase in the order rac-methohexitone, racthiopentone, rac-pentobarbitone, rac-secobarbitone, rac-hexobarbitone, amobarbitone and phenobarbitone (Lohse et al., 1987) . Stereoselective dierences in potency for individual barbiturates are also known. The relative potencies for racpentobarbitone and its enantiomers in potentiation of GABA responses in frog sensory neurons and cultured mammalian neurons are S-pentobarbitone4rac-pentobarbitone4R-pentobarbitone (Huang & Barker 1980; Akaike et al., 1987) .
The Hill slopes for both R-and S-thiopentone exceeded unity; this is consistent with the binding to the GABA A receptor of more than one agonist molecule to produce a GABA-evoked response (Colquhoun, 1998) . The ®nding is similar to that previously reported for pentobarbitone (Thompson et al., 1996) , and most probably re¯ects cooperativity of binding of agonist molecules to the GABA A receptor. Despite signi®cant dierences in EC 50 values for Rand S-thiopentone, no enantiomeric dierences in Hill coecients were found.
It has also been recently shown that dierences in GABA A subunits in¯uence the degree of drug ecacy obtained. The human GABA A a 1 b 2 g 2 subunit combination, as used in the present study, is thought to be a dominant combination in vivo (Lambert et al., 1997) . The GABA A receptor complex, however, is a multigene family. Thompson et al. (1996) described the in¯uence of various a and b subunits on the eects of rac-pentobarbitone. They found that GABA A receptors containing a 6 subunits, that are believed to be primarily located on cerebellar granule cells, had a higher anity and ecacy for the direct activation from racpentobarbitone than did other a subunits. In addition, the direct action of rac-pentobarbitone was not in¯uenced by dierences in b subunits to the same extent as the types of a subunits.
We found the relative potencies (EC 50 values) to be Sthiopentone5rac-thiopentone5R-thiopentone. The ®nding of a '2 fold higher EC 50 for R-thiopentone than S-thiopentone supports other studies describing a similar dierence in hypnotic potency (vide supra). Our study also showed that rac-thiopentone is 52-fold more potent than rac-pentobarbitone in its potentiation of the GABA response, a ®nding that is consistent with previous receptor binding studies. It is of interest that the EC 50 for the GABA response of racthiopentone (35 mM) in our study is comparable to the free fraction associated with a serum concentration of 200 mmol.l 71 with the degree of protein binding at *80% (Morgan et al., 1981) . This serum concentration clinically is associated with marked EEG slowing as well as a loss of motor activity to profound noxious stimuli (Hung et al., 1992) .
A dose-dependent response to dierent GABA concentrations in the presence of a ®xed concentration of pentobarbitone has been previously reported (Parker et al., 1986; Levitan et al., 1988) . Our ®ndings similarly demonstrate a leftward shift of the agonist dose-response curves for R-and Sthiopentone, as well as of rac-pentobarbitone, in the presence of a higher GABA concentration. A thiopentone enantiomeric dierence in potency, however, is still apparent under these conditions. The introduction of vigabatrin, a GABA transaminase inhibitor, and of tiagabine, a GABA transport reuptake inhibitor, has resulted in the clinical availability of anticonvulsants that primarily act by increasing brain GABA levels. Free cerebrospinal¯uid GABA concentrations in humans, for example, have been shown to increase 2 ± 4 fold after a 2 month treatment period of oral vigabatrin (BenMenachem 1989) . Hence it is conceivable that R-and Sthiopentone could exert a greater hypnotic eect if administered in the clinical setting of refractory status epilepticus to patients who are concurrently taking vigabatrin or tiagabine.
The eect of acidosis on the disposition of thiopentone has been studied previously. Brodie et al. (1950) reported that a pH of 6.8, induced by hypercarbia, resulted in decreased plasma thiopentone concentrations in dogs, and this was postulated have been caused by increased transfer of nonionized thiopentone into tissues. Hence, by increasing the uptake of thiopentone into brain and/or cerebrospinal¯uid, decreased pH could enhance the anaesthetic eect by a pharmacokinetic mechanism. However, it was previously unknown if a change in nonionized drug concentrations could also in¯uence the pharmacodynamic eect at a receptor level. Our study failed to demonstrate a signi®cant change in EC 50 values for either Ror S-thiopentone following a change in the cellular environment from pH 7.5 to 8.0 or pH 7.5 to 7.0.
In conclusion, S-thiopentone was found to be *2 fold more potent than R-thiopentone at potentiating the eects of GABA on GABA A receptors expressed on Xenopus oocytes. This dierence is comparable to dierences in hypnotic potency found previously in a small number of laboratory and clinical studies, most of which were performed over 20 years ago. Recent studies, however, have also indicated that relative lethal potential of S-thiopentone is increased disproportionately to R-thiopentone (Mather et al., unpublished observations) . Further studies may be of value in determining whether enantiopure thiopentone has a clinical pharmacological advantage over rac-thiopentone.
